Objective: The aim of this study was to compare the antihypertensive efficacy and tolerability of the calcium channel antagonist amlodipine besylate versus the angiotensin II type 1 receptor ...

Both therapeutic regimens (amlodipine besylate and candesartan cilexetil) were very effective in lowering office BP after 12 weeks of treatment. There was a trend towards better self-measured BP ...

Atracurium besylate 10mg/mL; soln for IV inj. <1month: not recommended. Individualize. 1month to 2yrs (under halothane anesthesia): initially 0.3–0.4mg/kg. ≥2yrs: initially 0.4–0.5mg/kg IV ...

The main treatment option currently is surgery, which carries high risks, including the recurrence of the tumour. Researchers from the Chinese Academy of Scientists found that a common blood pressure ...

Researchers from the Chinese Academy of Scientists found that a common blood pressure medicine, amlodipine besylate, has potent effects on the tumour. In their study, published in the journal ...